<DOC>
	<DOCNO>NCT02026089</DOCNO>
	<brief_summary>The purpose study learn abou immune system respond chickenpox vaccine adult never chickenpox child vaccinate adult . The study aim learn strength duration protection provide vaccine adult , observe immune response additional dose chickenpox vaccine adult receive vaccine least 5 year earlier . This especially relevant worker hospital may expose chickenpox .</brief_summary>
	<brief_title>Persistence Varicella Immunity Hospital Employees Receiving Varicella Vaccine</brief_title>
	<detailed_description>The population employee previously evaluate pre-employment phase Occupational Health Clinic ( OHC ) Colorado Children 's Hospital ( CHC ) 2004 2009 find seronegative varicella antibody time thus vaccinate per CHC protocol . Additionally , match number comparator subject positive varicella antibody pre-employment phase select pool ( 2004-2009 ) . Subject participation last 6 month . Subjects enrol one two study group : - Group 1 consist 50 subject test seronegative varicella antibody receive varicella vaccine meet employment criterion least 5 year previously ; - Group 2 consist 50 subject natural varicella infection thus test seropositive varicella antibody least 5 year previously . Group 1 subject receive 1 additional dose ( lifetime total 2 3 ) varicella vaccine ( Varivax ) participate total 4 study visit period 6 month . Before receive dose varicella vaccine Day 1 , Group 1 subject give CDC Vaccine Information Sheet varicella vaccine . Study staff review subject assure understand prior administer vaccine . Vaccination occur eligibility criterion confirm completion urine pregnancy test -with negative result - female childbearing potential . Following administration varicella vaccine , subject observe clinic least 15 minute safety . Blood ( 60 ml per sample ) collect Group 1 subject Day 1 immediately prior vaccination , Day 7 ( ±2 ) , Day 30 ( ±7 ) Day 180 ( ±14 ) order measure VZV-specific antibody , antibody avidity , cell-mediated immunity method indicate . Subjects receive third lifetime dose Varivax ask complete diary 5 day vaccination track anticipate unanticipated reaction vaccine . Group 2 subject , comparator group , receive vaccine participate first visit blood draw . Blood ( 60 ml ) collect Group 2 participant Day 1 . Subject information record include age ; gender ; varicella vaccine history OHC ; age vaccinate ( calculate interval since vaccination ) ; number dos ( 1 vs 2 ) receive ; exposure varicella HZ ( include involvement CHC outbreak work-up ) .</detailed_description>
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Age 1880 Group 1 : * Evaluated Occupational Health Clinic ( OHC ) employment 20042009 find seronegative varicella . Received least one varicella vaccination meet employment criterion least 5 year prior enrollment . Subject afebrile ( &lt; 100.4F oral ) day vaccination . Group 2 : * Evaluated OHC employment 2004 2009 find seropositive varicella . Immune suppress receive immune suppressive treatment Pregnant , breastfeed plan become pregnant within 6 week receive varicella vaccine . Receiving antiviral medication active varicella virus within 3 day varicella vaccination 10 day varicella vaccination . Receipt vaccine within 2 week enrollment expect receipt within 6 week vaccination . Receipt immunoglobulins blood product within 5 month prior study enrollment expect receipt prior last visit . History hypersensitivity reaction vaccine component ( include gelatin ) , anaphylactic/anaphylactoid reaction neomycin . History chickenpox shingle since preemployment serology test . Receipt additional varicella zoster vaccine since vaccination hospital policy procedure guideline . Currently participate study investigational compound within 30 day sign consent throughout participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>